Discover the top 25 companies transforming the real world evidence solutions market, including IQVIA, Merative, Optum, Inc., and other industry leaders. Backed by a market projected to grow from $5.42B to $10.8 B by 2030 at a CAGR of 14.8%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Real World Evidence Solutions Companies

IQVIA

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services dedicated to helping life sciences customers drive healthcare forward. The company’s Real-World Evidence (RWE) solutions leverage one of the world’s largest collections of healthcare data, including over 1.2 billion non-identified patient records, to provide deep insights into disease patterns and treatment outcomes. By combining proprietary data assets with advanced AI and machine learning through its Connected Intelligence framework, IQVIA enables pharmaceutical and biotech companies to optimize clinical development, demonstrate product value, and accelerate the commercialization of innovative therapies on a global scale.

Merative

Merative, formerly IBM Watson Health, is a data and analytics partner for the health industry, providing trusted technology and deep industry expertise to drive progress in clinical and social care. The company’s portfolio includes the renowned MarketScan research databases, which offer high-quality de-identified datasets essential for real-world evidence and health economics and outcomes research (HEOR). Merative serves a diverse client base, including life sciences companies, payers, and government agencies, helping them unlock the value of health information to improve decision-making, accelerate clinical trials, and enhance patient outcomes through data-driven insights.

Optum, Inc.

Optum, Inc., a division of UnitedHealth Group, is a technology-enabled health services business that integrates data and analytics with clinical expertise to improve the delivery and financing of healthcare. Through its OptumInsight segment, the company provides extensive real-world data and advanced analytical tools that support life sciences companies in evidence generation, market access, and population health management. By leveraging deep clinical datasets from its integrated provider and payer networks, Optum enables stakeholders to better understand patient journeys and develop value-based care strategies that lower costs and improve health results.

Icon PLC

Icon PLC is a premier global provider of outsourced drug and device development and commercialization services, specializing in clinical research and healthcare intelligence. The company offers a comprehensive suite of real-world evidence solutions, spanning from late-phase clinical trials and post-marketing surveillance to health economics and market access consulting. With its acquisition of PRA Health Sciences, Icon has significantly enhanced its data capabilities and digital health offerings, providing biopharmaceutical clients with the evidence-driven insights needed to navigate complex regulatory landscapes and demonstrate the long-term safety and efficacy of their products.

Syneos Health

Syneos Health is a leading fully integrated biopharmaceutical solutions organization that combines a contract research organization (CRO) and a contract commercial organization (CCO). The company’s real-world evidence services are designed to bridge the gap between clinical development and commercial success by utilizing advanced data analytics and real-world data to support medical affairs and market access strategies. Syneos Health’s end-to-end model allows it to generate actionable evidence that helps customers optimize trial designs, prove product value to payers, and improve patient adherence in real-world settings.

Parexel International (MA) Corporation

Parexel International is a major global clinical research organization that provides comprehensive drug development and market access services. The company’s real-world evidence division focuses on generating high-quality clinical and economic evidence through observational studies, patient registries, and the analysis of secondary data sources like electronic health records. Parexel’s expertise in regulatory consulting and health technology assessment (HTA) ensures that the evidence generated meets the rigorous requirements of global health authorities, helping clients maximize the value of their therapies throughout the entire product lifecycle.

Flatiron Health

Flatiron Health, a subsidiary of the Roche Group, is a healthtech leader specializing in the development of real-world evidence for oncology. By leveraging its proprietary electronic health record (EHR) platform and advanced data processing technologies, Flatiron creates high-quality, research-grade datasets that provide deep insights into cancer treatment patterns and patient outcomes. These real-world insights are utilized by life sciences companies and researchers to accelerate drug development, support regulatory submissions, and inform clinical decision-making, ultimately aiming to learn from the experience of every person with cancer.

Fortrea

Fortrea is a leading global contract research organization that emerged as a spin-off from Labcorp’s clinical development and commercialization business. The company provides a robust range of real-world evidence and post-approval solutions, helping biopharmaceutical clients demonstrate the long-term value and safety of their products in diverse patient populations. Fortrea’s deep therapeutic expertise and global site network enable it to execute complex observational studies and registries that provide critical insights into real-world treatment effectiveness and patient outcomes across the drug development continuum.

Oracle

Oracle, through its Oracle Life Sciences and Oracle Health divisions (including the acquisition of Cerner), provides a powerful ecosystem of cloud-based technology and real-world data solutions. Its platforms enable the integration of electronic health records with advanced analytics, facilitating the generation of real-world evidence at scale. Oracle’s solutions support clinical trial optimization, safety monitoring, and health outcomes research, helping life sciences organizations and healthcare providers derive actionable insights from massive datasets to improve therapeutic development and patient care delivery.

Elevance Health

Elevance Health, formerly Anthem, Inc., is a major health benefits company that leverages its extensive database of medical and pharmacy claims to drive real-world evidence research through its Carelon division. By analyzing data from millions of members, the company provides valuable insights into treatment pathways, cost-effectiveness, and population health trends. Elevance Health’s research capabilities support life sciences companies in developing evidence-based strategies for market access and clinical value demonstration, fostering a more sustainable and effective healthcare system.

SAS Institute Inc.

SAS Institute Inc. is a global leader in analytics and AI software, providing the foundational technology used by many life sciences organizations to process and analyze real-world data. Its specialized health analytics platforms allow researchers to integrate disparate data sources, perform complex statistical modeling, and generate the robust evidence required for regulatory and clinical decision-making. SAS’s commitment to data governance and advanced predictive modeling enables companies to uncover deep insights into patient safety, therapeutic efficacy, and health outcomes in real-world environments.

Aetion, Inc.

Aetion, Inc. is a leading healthcare technology company specializing in real-world evidence (RWE) through its Aetion Evidence Platform®. The company’s software enables biopharmaceutical companies, payers, and regulators to analyze real-world data—such as medical claims and electronic health records—to determine which treatments work best, for whom, and in what context. Aetion’s platform is recognized for its transparency and scientific rigor, often collaborating with organizations like the FDA to establish standards for the use of RWE in regulatory decision-making and value-based care.

Trinetx, LLC

TriNetX is a global health research network that provides real-time access to de-identified patient data from healthcare organizations worldwide. Its platform enables life sciences companies to optimize clinical trial design, identify eligible patient populations, and generate real-world evidence through a collaborative research ecosystem. By providing researchers with user-friendly tools for data query and analysis, TriNetX accelerates the discovery of medical breakthroughs and supports the development of more personalized and effective treatment strategies across numerous therapeutic areas.

Trinity

Trinity is a trusted strategic partner to the life sciences industry, offering a holistic suite of solutions that include strategy consulting, advanced analytics, and technology services. The company’s real-world evidence practice focuses on transforming complex real-world data into strategic insights that inform product development, market access, and commercialization. Trinity’s integrated approach combines deep industry knowledge with sophisticated data modeling, helping clients build compelling value stories and navigate the challenges of demonstrating therapeutic impact in real-world clinical practice.

Medidata

Medidata, a Dassault Systèmes company, is a leading provider of cloud-based clinical trial solutions and data analytics for the life sciences industry. Through its Medidata AI segment, the company offers real-world evidence solutions that leverage a vast repository of historical clinical trial data and integrated real-world data sources. Medidata’s platform enables researchers to create synthetic control arms, optimize trial protocols, and gain a more comprehensive understanding of patient experiences, thereby increasing the efficiency of drug development and the robustness of evidence generation.

Cognizant Technology Solutions Corporation

Cognizant is a global professional services company that provides extensive digital, technology, and consulting services to the life sciences sector. Its real-world evidence solutions focus on the digital transformation of evidence generation, utilizing cloud platforms, AI, and big data analytics to help pharmaceutical companies manage and analyze diverse real-world data sources. Cognizant enables clients to build integrated RWE infrastructures that support clinical development, pharmacovigilance, and value-based pricing, ultimately improving the speed and accuracy of evidence delivery.

Cegedim Health Data

Cegedim Health Data is a specialized provider of real-world data and real-world evidence, operating one of the largest European longitudinal patient databases, THIN® (The Health Improvement Network). The company provides life sciences companies, researchers, and health authorities with access to high-quality, de-identified data from primary care and hospitals across several European countries. Cegedim’s data services support a wide range of applications, including epidemiological studies, safety monitoring, and market access research, providing critical insights into healthcare practices and patient journeys in Europe.

Verantos

Verantos is a high-growth healthcare technology company that specializes in high-validity real-world evidence (RWE) through the use of advanced AI and natural language processing (NLP). The company’s platform focuses on extracting deep clinical insights from unstructured data within electronic health records, providing a more granular and accurate view of patient health than traditional claims-based data. Verantos partners with biopharmaceutical companies to generate regulatory-grade evidence that supports label expansions, safety monitoring, and the demonstration of therapeutic differentiation in complex disease areas.

Medpace

Medpace is a scientifically driven, global full-service contract research organization (CRO) that provides clinical development services for the biotechnology and pharmaceutical industries. Its real-world evidence solutions are integrated into its late-phase research services, focusing on the design and execution of observational studies, registries, and expanded access programs. Medpace’s core philosophy of physician-led clinical development ensures that RWE programs are scientifically rigorous and clinically relevant, providing sponsors with the high-quality data needed to support product value and long-term safety profiles.

Tata Consultancy Services Limited

Tata Consultancy Services (TCS) is a global leader in IT services and consulting that provides comprehensive digital health and real-world evidence solutions through its Life Sciences business unit. TCS leverages its expertise in AI, blockchain, and cloud computing to help biopharmaceutical companies build robust data ecosystems for evidence generation. Its services include the development of RWE platforms, data engineering, and advanced analytics, enabling organizations to gain deeper insights from real-world data to optimize clinical trials, enhance patient engagement, and demonstrate drug effectiveness.

HealthVerity, Inc.

HealthVerity is an innovative data technology company that provides a comprehensive platform for the discovery, license, and integration of de-identified patient data. Through its HealthVerity IPGE platform, the company offers access to a massive ecosystem of diverse data sources, including medical claims, pharmacy records, and lab results, all linked via a privacy-protecting identity solution. HealthVerity enables life sciences companies to build customized, longitudinal datasets for real-world evidence research, ensuring data interoperability and compliance with stringent privacy regulations.

OM1

OM1 is a specialized health technology and data company that focuses on generating real-world evidence for chronic and complex conditions through its high-quality, specialty-focused data networks. By utilizing advanced AI and machine learning, OM1 creates “Real-World Data Clouds” that provide deep clinical insights into patient outcomes and treatment effectiveness in areas such as immunology, neurology, and cardiology. These insights help life sciences companies, healthcare providers, and payers better understand disease progression and the real-world impact of therapies, supporting more personalized and value-driven healthcare.

Open Health

Open Health is a global medical communications and market access agency that provides integrated services to the pharmaceutical industry, including specialized real-world evidence solutions. The company’s RWE division focuses on generating and communicating evidence that demonstrates the value of medicines to payers and health technology assessment (HTA) bodies. Open Health combines clinical research expertise with strategic consulting and creative communications, helping clients navigate the complex path from evidence generation to global market access and commercial success.

Tempus

Tempus is a technology company at the forefront of AI-enabled precision medicine, utilizing its vast library of clinical and molecular data to generate real-world evidence. The company’s platform integrates genomic data with longitudinal clinical records to provide a multidimensional view of patient health and treatment response. Tempus partners with life sciences companies to accelerate clinical trial recruitment, discover novel biomarkers, and support regulatory submissions with high-quality real-world data, with a primary focus on improving outcomes for patients with cancer and other complex diseases.

Quantzig

Quantzig is a global analytics and advisory firm that provides specialized real-world evidence analytics solutions to the life sciences and healthcare industries. The company utilizes advanced statistical techniques and predictive modeling to help pharmaceutical companies analyze real-world data for market access, drug safety, and patient journey mapping. Quantzig’s insights enable clients to optimize their R&D investments, develop evidence-based pricing strategies, and improve the overall commercial performance of their products by better understanding real-world clinical and economic outcomes.

Download PDF Brochure:“Click Here”